Join to View Full Profile
100 Eastowne DrChapel Hill, NC 27514
Phone+1 984-974-5050
Fax+1 919-843-6899
Dr. Barnes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of North Carolina HospitalsFellowship, Gastroenterology, 2016 - 2017
Mass General Brigham/Brigham and Women's HospitalFellowship, Gastroenterology, 2013 - 2016- University of North Carolina HospitalsResidency, Internal Medicine, 2009 - 2012
University of South Carolina School of MedicineClass of 2009
Certifications & Licensure
NC State Medical License 2009 - 2026
TX State Medical License 2024 - 2025
MA State Medical License 2013 - 2016
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
Clinical Trials
- Improving Outcomes and Reducing Disparities for Patients With Inflammatory Bowel Disease Through Epidemiology and Enhanced Disease Management Start of enrollment: 2024 Jul 24
Roles: Contact
- A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC) Start of enrollment: 2024 Jun 12
Roles: Principal Investigator
Publications & Presentations
PubMed
- Primary Prevention of Pouchitis.Edward L Barnes, Hans Herfarth
Clinical Gastroenterology and Hepatology. 2025-08-01 - 1 citationsACG Clinical Guideline Update: Preventive Care in Inflammatory Bowel Disease.Francis A Farraye, Gil Y Melmed, Gary R Lichtenstein, Edward L Barnes, Berkeley N Limketkai
The American Journal of Gastroenterology. 2025-07-02 - MUSings on a Crohn's Disease Diagnosis.Meera Iyengar, Animesh Jain, Hans H Herfarth, Millie D Long, Edward L Barnes
Digestive Diseases and Sciences. 2025-06-26
Authored Content
- Q&A: Updated AGA Guidance on Managing Post-IPAA PouchitisSeptember 2024
Press Mentions
Edward Barnes, MD, on Antibiotics and Risk of PouchitisMay 6th, 2025- Weekly Roundup: 14 Health Press Releases You Need to SeeFebruary 14th, 2025
- Most Patients on Lilly's Omvoh® (Mirikizumab-Mrkz) for Crohn's Disease Achieved Sustained Clinical Remission and Endoscopic Response at Two YearsFebruary 7th, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
